These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1042 related articles for article (PubMed ID: 25188031)

  • 1. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
    Maciuca IE; Williams NJ; Tuchilus C; Dorneanu O; Guguianu E; Carp-Carare C; Rimbu C; Timofte D
    Microb Drug Resist; 2015 Dec; 21(6):651-62. PubMed ID: 25734920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spread of CTX-Type Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates of Epidemic Clone B2-O25-ST131 Among Dogs and Cats in Japan.
    Kawamura K; Sugawara T; Matsuo N; Hayashi K; Norizuki C; Tamai K; Kondo T; Arakawa Y
    Microb Drug Resist; 2017 Dec; 23(8):1059-1066. PubMed ID: 28380311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
    Namaei MH; Yousefi M; Ziaee M; Salehabadi A; Ghannadkafi M; Amini E; Askari P
    Microb Drug Resist; 2017 Oct; 23(7):879-884. PubMed ID: 28437226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
    Matsumura Y; Yamamoto M; Higuchi T; Komori T; Tsuboi F; Hayashi A; Sugimoto Y; Hotta G; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Int J Antimicrob Agents; 2012 Aug; 40(2):158-62. PubMed ID: 22743014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-mediated resistance to cephalosporins and fluoroquinolones in various Escherichia coli sequence types isolated from rooks wintering in Europe.
    Jamborova I; Dolejska M; Vojtech J; Guenther S; Uricariu R; Drozdowska J; Papousek I; Pasekova K; Meissner W; Hordowski J; Cizek A; Literak I
    Appl Environ Microbiol; 2015 Jan; 81(2):648-57. PubMed ID: 25381245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.
    Valenza G; Werner M; Eisenberger D; Nickel S; Lehner-Reindl V; Höller C; Bogdan C
    J Glob Antimicrob Resist; 2019 Jun; 17():305-308. PubMed ID: 30682563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.
    Blanco J; Mora A; Mamani R; López C; Blanco M; Dahbi G; Herrera A; Blanco JE; Alonso MP; García-Garrote F; Chaves F; Orellana MÁ; Martínez-Martínez L; Calvo J; Prats G; Larrosa MN; González-López JJ; López-Cerero L; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2011 Sep; 66(9):2011-21. PubMed ID: 21669946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qep in ESBL-producing Escherichia coli clinical isolates from Egypt.
    Hassan WM; Hashim A; Domany R
    Indian J Med Microbiol; 2012; 30(4):442-7. PubMed ID: 23183470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.
    Park SH; Byun JH; Choi SM; Lee DG; Kim SH; Kwon JC; Park C; Choi JH; Yoo JH
    BMC Infect Dis; 2012 Jun; 12():149. PubMed ID: 22747570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community.
    Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
    Microb Pathog; 2013; 61-62():16-22. PubMed ID: 23643553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage.
    Hussain A; Ewers C; Nandanwar N; Guenther S; Jadhav S; Wieler LH; Ahmed N
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6358-65. PubMed ID: 23045357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.